RxEvent launched to aid physicians, manufacturers and the US FDA

- Last updated on GMT

Related tags: Adverse events, Food and drug administration

A new online adverse drug event (ADE) network will improve the quality of data and, ultimately, boost drugmakers’ cost-efficiencies according to developer PDR Network.

The RxEvent system is designed to allow physicians to report adverse events via their electronic health records (HER) platforms. This data can then be passed directly to drug makers and the US Food and Drug Administration (FDA).

PDR, a distributor of FDA-approved labelling data, alerts and REMS information, developed RxEvent in partnership with Greenway Medical Technologies, American Pharmacists Association and athenahealth.

The firm explained that, according to some studies as physicians and pharmacists report as few as one in 10 of the adverse events they encounter “due to the time-consuming and inefficient processes involved​.”

This may mean that as many as 4.5m ADEs each year go unreported, putting patients at risk, skewing drugmakers triage efforts and investigation strategies and potentially affecting decisions made by the FDA.

Related news

Show more

Related products

show more

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Follow us


View more